HCG 10000 IU Peptide | Human Chorionic Gonadotropin |

⚠️ ATTENTION: STRICTLY FOR LABORATORY RESEARCH USE ONLY.
This product is NOT FOR HUMAN CONSUMPTION, medical use, veterinary use, or diagnostic use. By purchasing, you agree to handle this compound in compliance with all local and federal regulations.

The Apex of Endocrine Signaling & HPG Axis Research

Human Chorionic Gonadotropin (HCG) is a highly active, naturally occurring heterodimeric glycoprotein hormone. While it is fundamentally analogous to endogenous Luteinizing Hormone (LH) produced by the pituitary gland, HCG offers profoundly enhanced biological stability and receptor affinity. In the specialized fields of reproductive endocrinology, advanced hormone optimization, and post-cycle stabilization research, this high-yield HCG 10000 IU formulation is recognized as the definitive clinical-grade concentration necessary for extended, multi-phase laboratory protocols.

While traditional regenerative peptides target localized tissue repair and incretin-based peptides govern metabolic energy expenditure, HCG acts directly and aggressively on the hypothalamic-pituitary-gonadal (HPG) axis. It is extensively utilized in in-vivo and in-vitro research models to investigate the stimulation of endogenous (internal) hormone production, directly contrasting the suppressive nature of exogenous hormone replacement therapies. By acting as a structural and functional mimic of LH, HCG serves as a master signaling molecule. It prompts biological systems to maintain active gonadal function, preserve cellular volume, and rapidly restore complete hormonal equilibrium following periods of severe chemical or physiological suppression.

The Biochemistry of LHCGR Activation & Steroidogenesis

The therapeutic potential and sustained efficacy of HCG lie in its precise, non-metabolic signaling cascade. It functions strictly through neuroendocrine and gonadal pathways, bypassing standard hypothalamic feedback bottlenecks.

When introduced into a research model, the molecular mechanism of action unfolds through the following precise biological steps:

1. Receptor Binding: HCG possesses an exceptionally high binding affinity for the Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR), a G-protein-coupled receptor located primarily on the surface of specific gonadal cells.

2. Intracellular Cascade: Upon successful binding, it activates the Gs and Gq proteins, which subsequently triggers the adenylate cyclase enzyme.

3. cAMP Elevation: This activation leads to a rapid and sustained elevation of intracellular cyclic AMP (cAMP).

4. Steroidogenesis (Male Models): In male research models, this cAMP spike directly stimulates the Leydig cells within the testes. The Leydig cells respond by upregulating the conversion of cholesterol into pregnenolone, dramatically accelerating the natural production of testosterone.

5. Ovarian Stimulation (Female Models): In female models, this cascade triggers terminal follicular maturation, mimics the natural LH surge required for ovulation, and maintains the corpus luteum for sustained progesterone synthesis.

Comparative Advantage: HCG 10000 IU vs Endogenous Luteinizing Hormone (LH)

A frequent subject of laboratory investigation is why researchers utilize HCG rather than synthesizing standard LH for endocrine stimulation. The answer lies in the molecular structure of the peptide chain.

Both LH and HCG share an identical alpha subunit, but their beta subunits differ. The beta subunit of HCG contains an additional 24-amino-acid Carboxyl-Terminal Peptide (CTP) tail. This heavily glycosylated structural extension protects the molecule from rapid enzymatic degradation.

• Endogenous LH Half-Life: 1 to 2 hours.

• HCG Biological Half-Life: 24 to 36 hours.

This extended stability makes HCG vastly superior for maintaining sustained LHCGR activation, allowing for consistent gonadal stimulation without the need for constant, hourly administration in laboratory settings.

Primary Domains of Laboratory Investigation

1. Endogenous Testosterone Production & TRT Stabilization

HCG is intensely studied for its capacity to stimulate the natural production of testosterone independently of pituitary signals. Traditional Testosterone Replacement Therapy (TRT) introduces exogenous androgens, which the hypothalamus detects, causing a negative feedback loop that completely shuts down native LH production. Advanced research models demonstrate that by administering HCG alongside TRT compounds, the LHCGR remains actively stimulated. This prevents endocrine shutdown and maintains a biologically “awake” state within the gonads.
(Evidence Level: ⭐⭐⭐⭐⭐)

2. Prevention of Gonadal Atrophy & Apoptosis

In laboratory models studying the effects of long-term suppressive therapies (such as high-dose androgen exposure), HCG is uniquely utilized to observe the prevention of gonadal atrophy. Without LH signaling, Leydig cells shrink and may undergo apoptosis (programmed cell death). By keeping these cells actively engaged in steroidogenesis, the high-yield 10,000 IU HCG formulation preserves testicular volume, maintains structural cellular integrity, and prevents the complete deterioration of the biological hormone factory.
(Evidence Level: ⭐⭐⭐⭐☆)

3. Fertility, Gametogenesis & Reproductive Function

Due to its direct structural homology to LH, HCG is a premier compound in fertility medicine research. It is widely investigated for its ability to promote robust spermatogenesis in male models by maintaining the high intratesticular testosterone levels required for sperm maturation. In female models, it is the standard compound used to trigger final follicular rupture (ovulation), making it an indispensable tool for studying mammalian reproductive viability.
(Evidence Level: ⭐⭐⭐⭐⭐)

4. Post-Cycle Therapy (PCT) & HPG Axis Rebooting

Following severe HPG axis suppression, the biological system can take months to naturally restart LH and FSH production. HCG 10,000 IU is frequently deployed in Post-Cycle Therapy (PCT) research protocols to investigate the rapid restoration of natural hormone signaling. It effectively acts as a biological “jumper cable,” artificially stimulating the gonads to produce testosterone while the suppressed hypothalamus and pituitary slowly recover their natural rhythmic pulsing.
(Evidence Level: ⭐⭐⭐⭐☆)

Laboratory Handling & Reconstitution Protocols :

Due to the delicate glycoprotein structure of this high-capacity 10,000 IU formulation, precise laboratory handling is required to maintain molecular integrity:

• Solvent Compatibility: Must be reconstituted exclusively with sterile Bacteriostatic Water or strictly calibrated sodium chloride injection solutions.

• Agitation Warning: Lyophilized HCG is highly susceptible to mechanical sheer stress. During reconstitution, the solvent must be introduced slowly down the side of the glass vial. Never shake the vial; gently swirl to dissolve the glycoprotein lattice.

• Storage Stability: Prior to reconstitution, the lyophilized powder can be stored at controlled room temperature. Once reconstituted, the 10ML liquid solution must be immediately refrigerated between 2°C and 8°C (36°F and 46°F) to prevent peptide degradation.

Laboratory Specifications & Compound Profile :

This specific formulation is engineered by Resurrection Peptides for research institutions requiring absolute precision and maximum yield per vial for longitudinal studies.

• Product Classification: Heterodimeric Glycoprotein Hormone.

• Molecular Weight: Approximately 36,000 g/mol (consisting of heavily glycosylated alpha and beta subunits).

• Amino Acid Chain: 237 amino acids total (92 alpha subunit, 145 beta subunit).

• Dosage / Yield: High-Capacity 10,000 IU (International Units).

• Volume Capacity: 10ML standard clinical research vial format.

• Purity Standard: 99%+ (Independent Third-Party Lab Verified for structural integrity, correct folding, and biological activity).